Contemporary paradigm for the evaluation and treatment of hereditary gastric cancer

N. Skill, Mary Maluccio

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Gastric cancer is the third leading cause of cancer mortality worldwide. Survival is linked to stage at diagnosis and tolerance to surgery and adjuvant therapy. The emergence of sophisticated methods to identify patients at high risk for the development of gastric cancer has given us an opportunity to eliminate a lethal disease in an identifiable patient population. Guidelines and recommendations have been established and prophylactic total gastrectomy is considered the most effective treatment. However, this requires substantial physical and emotional investment. It is imperative that patients and families are supported by genetic counseling, ongoing surveillance, and survivorship studies.

Original languageEnglish (US)
Article number14
JournalTranslational Gastroenterology and Hepatology
Volume4
DOIs
StatePublished - Feb 1 2019

Fingerprint

Stomach Neoplasms
Genetic Counseling
Gastrectomy
Therapeutics
Survival Rate
Guidelines
Survival
Mortality
Population
Neoplasms

Keywords

  • CDH-1
  • Genetic counseling
  • Hereditary diffuse gastric cancer (HDGC)
  • Prophylactic total gastrectomy
  • Quality of life

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Contemporary paradigm for the evaluation and treatment of hereditary gastric cancer. / Skill, N.; Maluccio, Mary.

In: Translational Gastroenterology and Hepatology, Vol. 4, 14, 01.02.2019.

Research output: Contribution to journalReview article

@article{f6538b64bf894f1a8cdad8ebfa630333,
title = "Contemporary paradigm for the evaluation and treatment of hereditary gastric cancer",
abstract = "Gastric cancer is the third leading cause of cancer mortality worldwide. Survival is linked to stage at diagnosis and tolerance to surgery and adjuvant therapy. The emergence of sophisticated methods to identify patients at high risk for the development of gastric cancer has given us an opportunity to eliminate a lethal disease in an identifiable patient population. Guidelines and recommendations have been established and prophylactic total gastrectomy is considered the most effective treatment. However, this requires substantial physical and emotional investment. It is imperative that patients and families are supported by genetic counseling, ongoing surveillance, and survivorship studies.",
keywords = "CDH-1, Genetic counseling, Hereditary diffuse gastric cancer (HDGC), Prophylactic total gastrectomy, Quality of life",
author = "N. Skill and Mary Maluccio",
year = "2019",
month = "2",
day = "1",
doi = "10.21037/tgh.2019.01.13",
language = "English (US)",
volume = "4",
journal = "Translational Gastroenterology and Hepatology",
issn = "2224-476X",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Contemporary paradigm for the evaluation and treatment of hereditary gastric cancer

AU - Skill, N.

AU - Maluccio, Mary

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Gastric cancer is the third leading cause of cancer mortality worldwide. Survival is linked to stage at diagnosis and tolerance to surgery and adjuvant therapy. The emergence of sophisticated methods to identify patients at high risk for the development of gastric cancer has given us an opportunity to eliminate a lethal disease in an identifiable patient population. Guidelines and recommendations have been established and prophylactic total gastrectomy is considered the most effective treatment. However, this requires substantial physical and emotional investment. It is imperative that patients and families are supported by genetic counseling, ongoing surveillance, and survivorship studies.

AB - Gastric cancer is the third leading cause of cancer mortality worldwide. Survival is linked to stage at diagnosis and tolerance to surgery and adjuvant therapy. The emergence of sophisticated methods to identify patients at high risk for the development of gastric cancer has given us an opportunity to eliminate a lethal disease in an identifiable patient population. Guidelines and recommendations have been established and prophylactic total gastrectomy is considered the most effective treatment. However, this requires substantial physical and emotional investment. It is imperative that patients and families are supported by genetic counseling, ongoing surveillance, and survivorship studies.

KW - CDH-1

KW - Genetic counseling

KW - Hereditary diffuse gastric cancer (HDGC)

KW - Prophylactic total gastrectomy

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=85063860725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063860725&partnerID=8YFLogxK

U2 - 10.21037/tgh.2019.01.13

DO - 10.21037/tgh.2019.01.13

M3 - Review article

AN - SCOPUS:85063860725

VL - 4

JO - Translational Gastroenterology and Hepatology

JF - Translational Gastroenterology and Hepatology

SN - 2224-476X

M1 - 14

ER -